SEC Form 4 · accession 0001209191-15-018504
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2015 | M | 860 | $83.36 | A | 21,485 | D | |
| Common Stock | Feb 23, 2015 | M | 1,290 | $77.31 | A | 22,775 | D | |
| Common Stock | Feb 23, 2015 | S | 2,150 | $119.85 | D | 20,625 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $83.36 | Feb 23, 2015 | M | 860 | D | — | Jul 29, 2023 | Common Stock | 860 | 8,593 | D |
| Stock Option (right to buy)F3 | $77.31 | Feb 23, 2015 | M | 1,290 | D | — | Feb 4, 2024 | Common Stock | 1,290 | 15,468 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2The option vests in 16 quarterly installments from 07/30/2013.
- F3The option vests in 16 quarterly installments from 02/05/2014.